药剂师在纽约州处方激素避孕药:有需要和兴趣吗?
概括
在纽约接受调查的大多数女性都对药剂师处方荷尔蒙避孕药感到满意,这种变化可以减少避孕措施的障碍. 进一步的教育可能会增加这种直接药店接入 (DPA) 的接受率.
科学领域:
- 生殖健康 生殖健康
- 药房实践 在药房实践中
- 公共卫生 公共卫生
背景情况:
- 荷尔蒙避孕药广泛用于预防怀孕,需要处方.
- 药房直接接入 (DPA) 允许药剂师启动激素避孕药,这是24个州采用的模式.
- 纽约州 (NYS) 以前限制了DPA,但在2023年颁布了立法,允许药剂师发行药品.
研究的目的:
- 评估女性对获得荷尔蒙避孕药的经验和看法.
- 为了评估意识和舒适度,药剂师开始使用荷尔蒙避孕药.
- 确定从医疗保健提供者获得荷尔蒙避孕药的障碍.
主要方法:
- 在纽约州对500名16至44岁的女性进行了在线调查.
- 该调查包括有关人口统计,避孕药的使用以及有关药剂师主导启动的意见的问题.
- 统计分析 (基平方测试) 检查了人口统计学与避孕药使用的关联.
主要成果:
- 大多数受访者 (76.2%过去,76.8%目前/计划) 使用激素避孕药.
- 访问的主要障碍包括预约安排和供应商等待时间.
- 大多数受访者 (74.2%) 对药剂师处方和分发激素避孕药感到满意,尽管其他州对DPA的认识很低 (72.6%).
结论:
- 对于大多数受访女性来说,药剂师开始使用荷尔蒙避孕药是可以接受的.
- 直接进入药房有潜力减轻已识别的避孕障碍.
- 增加患者教育和经验可以进一步提高药剂师主导的避孕服务的接受度.
相关概念视频
Birth Control Methods
376
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
376
Prescription, Nonprescription and Orphan Drugs
789
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
789
Hormonal Control of the Ovarian Cycle
593
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
593
Hormonal Regulation
33.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.4K
Hormonal Regulation of the Menstrual Cycle
469
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
469
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K


